New findings and controversies in odontogenic tumors by Mosqueda Taylor, Adalberto
E555
Med Oral Patol Oral Cir Bucal. 2008 Sep1;13(9):E555-8.                                                                                                                                                                           New findings in odontogenic tumors                                                                           Med Oral Patol Oral Cir Bucal.  2008 Sep1;13(9):E555-8.                                                                                                                                                                           New findings in odontogenic tumors
New findings and controversies in odontogenic tumors
Adalberto Mosqueda Taylor
Head of the Clinical Research Area, Health Care Department, Universidad Autónoma Metropolitana Xochimilco. México, D.F.
Correspondence:
Prof. Adalberto Mosqueda Taylor
Departamento de Atención a la Salud
Universidad Autónoma Metropolitana Xochimilco






Accepted: 10/07/2008 Mosqueda-Taylor A. New findings and controversies in odontogenic 
tumors. Med Oral Patol Oral Cir Bucal. 2008 Sep1;13(9):E555-8.
© Medicina Oral S. L. C.I.F. B 96689336 - ISSN 1698-6946
http://www.medicinaoral.com/medoralfree01/v13i9/medoralv13i9p555.pdf
Abstract
Odontogenic tumors comprise a heterogeneous group of lesions that ranges from hamartomas to benign and malignant 
neoplasms of variable aggressiveness. This article shows how the lack of uniform criteria employed for their proper 
identification, as well as the histomorphologic similitude found among some of them which behaves in different way, 
and the scantiness of proper methods to determine their precise origin makes necessary to recognize that at present, 
in spite of having more or less strict diagnostic criteria which have been internationally accepted, there is a need to 
continue developing research in the epidemiological, clinico-pathological, morpho-physiological and therapeutical 
fields in this area of the maxillofacial pathology.  
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Introduction
Odontogenic tumors (OT) are lesions that derive from 
the tooth-producing tissues or their remnants that remain 
entrapped either within the jawbones or into the adjacent 
soft tissues. From a biological point of  view, some of 
these lesions represent hamartomas with varying degrees 
of differentiation, while the rest are benign or malignant 
neoplasms with variable aggressiveness and potential to 
develop metastasis. 
Since the first attempt to classify these lesions published 
by Broca in 1868 (1), numerous works have been done in 
this respect, but it was not until the 1960´s decade, when a 
group of experts from different countries, sponsored by the 
World Health Organization produced a consensus-based 
classification aimed to define the clinico-pathological 
criteria necessary to diagnose these entities. This effort 
lead in 1971 to the publication of the first edition of the 
“Histological Classification of  Odontogenic Tumours, 
Jaw Cysts and Allied Lesions”, which had Professors Jens 
J. Pindborg and Ivor R.H. Kramer as editors (2). Due to 
the very low incidence of many of the lesions included 
in that work, as well as to the need of re-classification of 
some of them because of advances in knowledge of the 
oral and maxillofacial embriology and the identification 
of new entities during the following years, it was neces-
sary to update that classification, and the second edition 
appeared in 1992, headed by Professors Kramer, Pindborg 
and Mervyn Shear (3). Since then, the development of 
new technologies in diagnostic immunohistochemistry, 
molecular biology and genetics, as well as the clinical and 
epidemiological follow-up of some of the lesions included 
in the previous editions, disclosed the need of re-classify 
some of them according to their probable histogenesis 
(e.g. adenomatoid odontogenic tumor is now classified 
as an epithelial tumor without odontogenic ectomesen-
chyme), or according to their biological behavior (the 
former clear cell odontogenic tumor is now identified as 
a type of carcinoma, and the odontogenic keratocyst is 
considered as a benign locally aggressive neoplasm that 
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has been re-named as keratocystic odontogenic tumor). 
These and other important changes have been included 
in the most recent WHO classification of head and neck 
tumors published in 2005, which is a guide for diagnosis 
of these lesions nowadays and was produced with the co-
llaboration of numerous colleages from countries of the 
five continents, headed by Prof. Peter Reichart from the 
University of Berlin (4). It is well known that classifica-
tions had a short life, depending on the persistence of the 
basic concepts that support the existence of a given entity, 
and therefore one can expect that in the future some of 
the less common lesions known nowadays or those as yet 
unclassified odontogenic tumors may be properly defined 
in future editions of this classification.
At present, it is known that the potential sources to deve-
lop an odontogenic tumor are varied, and these include:
1. The pre-functional dental lamina (odontogenic epi-
thelium with ability to produce a tooth), which is more 
abundant for obvious reasons distally to the lower third 
molars.
2. The post functional dental lamina, a concept that covers 
those epithelial remnants such as Serre´s epithelial rests, 
located within the fibrous gingival tissue; the epithelial 
cell rests of Malassez in the periodontal ligament and the 
reduced enamel organ epithelium, which covers the enamel 
surface until tooth eruption.
3. The basal cell layer of the gingival epithelium, which 
originally gave rise to the dental lamina.
4. The dental papilla, origin of the dental pulp, which has 
the potential to be induced to produce odontoblasts and 
synthesize dentin and/or dentinoid material.
5. The dental follicle.
6. The periodontal ligament, which has the potential to 
induce the production of fibrous and cemento-osseous 
mineralized material.
 
The lack of specific markers to confirm the odontogenic 
origin of all the lesions included in the current W.H.O. 
classification makes diagnosis to be based mainly in ana-
tomic considerations, dentigerous relationship or in the 
histomorphological similarities among some tumors with 
the above mentioned odontogenic structures. However, 
as most OT contain variable amounts of epithelium, and 
the fact that such tissue may express several of the more 
than 20 cytokeratin markers (intermediate filaments of 
the epithelial cells) known to date, there are some studies 
that have demonstrated that cytokeratins 14 and 19 are 
the more frequently expressed by OT, and that these are 
also expressed in the different epithelial structures of the 
developing tooth (5,6), leading to promote their use as 
a diagnostic tool to support the odontogenic nature of 
these entities. Additionally, the expression of ameloge-
nin, a representative protein of the enamel matrix, which 
is produced by secretory ameloblasts and that seem to 
actively participate in the process of production and mine-
ralization of enamel, has been consistently demonstrated 
within the enamel matrix and the cytoplasm of the cells 
of the reduced enamel epithelium, stratum intermedium 
and stellate reticulum of the enamel organ, as well as in 
some epithelial OT, particularly at the basal endings of 
the cuboidal or columnar cells of ameloblastomas and in 
cells of calcifying epithelial odontogenic tumor, malignant 
ameloblastoma and ameloblastic carcinoma (6). Therefo-
re, the use of these markers is a valuable tool to discard 
other types of epithelial lesions that may develop within 
the oral and maxillofacial regions. More recently, calre-
tinin, a 29-kDa calcium-binding protein has been shown 
to be expressed in both unicystic and solid ameloblasto-
mas but not in other types of odontogenic cysts, and this 
finding led some authors to propose it may be considered 
a specific immunohistochemical marker for neoplasitic 
ameloblastic epithelium (7) and an important diagnostic 
aid in the differential diagnosis of  cystic odontogenic 
lesions, particularly the keratocystic odontogenic tumor 
(8).  In the same way, the expression of cytodifferentia-
tion of neoplastic epithelium via epithelial-mesenchymal 
interactions and mineralization markers, such as bone 
morphogenetic protein (BMP) is of great value to study 
those lesions that are characterized by the production of 
hard dental tissues (9,10). 
OT are very infrequent lesions as compared to other pa-
thologic processes of the oral and maxillofacial regions, 
as some studies have shown that these represent between 
0.8% and 3.7% of all specimens sent to oral pathology 
laboratories (11-13). More than 95% of all OT reported 
in large series are benign and around 75% are represented 
by odontomas, ameloblastomas and myxomas (which 
could be considered as “relatively frequent OT”). Due to 
the inclusion of the odontogenic keratocyst as a tumor, 
these figures will be modified significatively, as this lesion 
is more frequently diagnosed than the other three enti-
ties. Some studies have shown epidemiological data that 
demonstrate that there is a second group of OT, which, 
although rare in terms of general pathology, are of “inter-
mediate frequency” with respect to other OT, which have 
to be considered in the differential diagnosis of tumors 
of the oral and maxillofacial regions and therefore have 
to be included within the contents of pathology of the 
graduate and post-graduate courses of oral and general 
pathology. This group of lesions includes adenomatoid 
odontogenic tumor (AOT), calcifying cystic odontogenic 
tumor (previously known as calcifying odontogenic cyst 
or Gorlin´s cyst), ameloblastic fibroma, ameloblastic 
fibro-odontoma, peripheral odontogenic fibroma and 
cementoblastoma, which have relative frequencies usually 
above 1% and less than 10% of all OT. Finally, there is 
a less common group of lesions, considerd as “very low 
frequency” tumors, as each of them represent less than 
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1% of all OT in most of the published series worldwide. 
These include the calcifying epithelial odontogenic tumor 
(Pindborg´s tumor), squamous odontogenic tumor, ame-
loblastic fibro-dentinoma, odontoameloblastoma, ghost 
cell dentinogenic tumor, central odontogenic fibroma and 
all variants of the malignant OT (14).  
Epidemiological studies are important because they allow 
to know more precisely the occurrence of these lesions 
in the diverse populations, which in turn help to identify 
the groups at risk and posible factors associated to their 
development. In this respect, and as an example of this 
situation, there are studies that demonstrate that in Africa 
solid/multicystic  ameloblastomas are more frequent than 
unicystic subtypes, while in Latin American population 
the unicystic subtypes (which pose a better prognosis) 
are more frequent than solid neoplasms (15). The main 
problem to allow comparison among the different studies 
is that there are no uniform criteria employed in most 
of the previously published works, since although some 
authors used criteria based on the W.H.O. classifications, 
other used different definitions or older concepts that 
includes more than one lesion under a single designation 
(for example, all subtypes of ameloblastoma were very 
often considered as a single diagnostic category, making 
no distinction among the four subtypes known to date). 
In the same way, there are works that show wide variations 
with respect to the relative frequency of the diverse OT, 
as there are some series that do not include odontomas 
in their results, possibly because these are asymptomatic 
lesions that are usually removed in the dental office and 
they frequently are not sent to the laboratory for histopa-
thological analysis or, even worst, very often these lesions 
are only diagnosed on clinico-radiological grounds, which 
produces an under-estimation of their true frequency in 
many of the published series (16). Odontomas are ha-
martomatous lesions that usually do not produce clinical 
symptomatology but sometimes may be associated to 
other OT, such as calcifying cystic odontogenic tumor or 
may develop dentigerous cysts (“cystic odontoma”) and 
therefore the lack of histopathological analysis of every 
sample may underestimate the true frequency of these and 
other possibly related lesions; in addition, it is important 
to remember that there are certain syndromes, such as 
Gardner syndrome and some other in which odontomas, 
particularly when multiple, may be one of the earlier mani-
festations of the genetic disorders and their identification 
allow an early diagnosis and may improve its prognosis 
favoring an early and proper management of the more 
severe manifestations of such syndromes (17,18). 
Regarding the mesenchymal and ectomesenchymal 
odontogenic tumors, it is not clearly demonstrated the 
exact source of some of them. For example, although the 
classical image of the odontogenic myxoma seem to be at 
first sight similar to the dental papilla or the dental follicle, 
there are marked differences between them, as for exam-
ple, the amount and types of proteoglycan they contain. 
In this respect, some authors have found that hyaluronic 
acid concentration in odontogenic myxomas is four times 
higher than those of other glycosaminoglycans, such as 
chondroitin sulphate, which is inverse to what has been 
found in mesenchymal tissues from dental pulp, gingiva 
and periodontal ligament (19-21). Other have suggested 
that the characteristic microscopic aspect of this neoplasm 
could be the result of a myxoid change in a pre-existent 
mesenchymatous lesion or that it may represent a dege-
nerative form of odontogenic fibroma (22). In addition, a 
recent study which analyzed the clinico-pathological and 
immunohistochemical features of 62 cases of odontogenic 
myxomas found that in this lesion a varied mesenchymal 
cellular population do exist, in which the specific role the 
myofibroblasts, mast cells and their products play is still 
not defined. In the same way, only a small percentage of 
these cases exhibited epithelial islands and interestingly, 
most of them did not express immunophenotypic features 
suggestive of odontogenic origin (positivity to CK 14 and 
CK 19), and therefore the presumed odontogenic nature 
of this neoplasm remain to be determined. The authors 
concluded that odontogenic myxoma is a mesenchymal 
neoplasm in which there are several factors that may 
contribute to its pathogenesis and expansion (23).
Finally, other problems that remain to be resolved are 
derived from the very low frequency of some OT, such as 
odontoameloblastoma, the recognition of  some odon-
togenic lesions not yet included in the current W.H.O. 
classification (for example, adenomatoid odontogenic 
hamartoma) and the position on the biological spectrum 
of those hybrid odontogenic tumors (for example, cases 
of ameloblastic fibromas or fibro-odontomas with cal-
cifying cystic odontogenic tumor, central odontogenic 
fibromas with giant cell lesions and some other combi-
nations), as there is not enough experience to determine 
the proper therapeutic behavior in such cases; therefore, 
it is encouraged the report of these kind of cases as well 
as to carry out studies directed towards the identification 
of their pathogenesis and their possible relationship with 
well established entities and to know more about their 
biological behavior on the long term.
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